International Clinical Research Center
Address: | Pekařská 664/53, 602 00 Brno, Pavilion A1 |
---|
Phone: | +420 543 182 692 |
---|---|
E-mail: |
Total number of publications: 48
Articles
-
Intravenous Thrombolysis in Posterior versus Anterior Circulation Stroke: Clinical Outcome Differs Only in Patients with Large Vessel Occlusion
Biomedicines, year: 2024, volume: 12, edition: 2, DOI
-
Levodopa may modulate specific speech impairment in Parkinson's disease: an fMRI study
Journal of Neural Transmission, year: 2024, volume: 131, edition: 2, DOI
-
Long circulating liposomal platform utilizing hydrophilic polymer-based surface modification: preparation, characterisation, and biological evaluation
International Journal of Pharmaceutics, year: 2024, volume: 661, edition: August 2024, DOI
-
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE) : a randomised controlledtrial
Lancet, year: 2024, volume: 404, edition: 10448, DOI
-
Multi-channel delineation of intracardiac electrograms for arrhythmia substrate analysis using implicitly regularized convolutional neural network with wide receptive field
Biomedical Signal Processing and Control, year: 2024, volume: 94, edition: August 2024, DOI
-
NeuroRoots, a bio-inspired, seamless brain machine interface for long-term recording in delicate brain regions
AIP Advances, year: 2024, volume: 14, edition: 8, DOI
-
Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI
Hellenic Journal of Cardiology, year: 2024, volume: 76, edition: March-April 2024, DOI
-
Parkinson´s disease cardiovascular symptoms: A new complex functional and structural insight
European Journal of Neurology, year: 2024, volume: 31, edition: 2, DOI
-
Penumbral Rescue by normobaric O?=?O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial
International Journal of Stroke, year: 2024, volume: 19, edition: 1, DOI
-
Persisting IL-18 levels after COVID-19 correlate with markers of cardiovascular inflammation reflecting potential risk of CVDs development
Heliyon, year: 2024, volume: 10, edition: 4, DOI